[1]
2021. Nintedanib in the management of pulmonary fibrosis after COVID-19: a case report. BIRDEM Medical Journal. 11, 2 (Apr. 2021), 148–152. DOI:https://doi.org/10.3329/birdem.v11i2.53139.